Background and Objectives: Anaplastic thyroid carcinoma (ATC) is commonly related with concurrent differentiated thyroid carcinoma (DTC). We aimed to examine the clinicopathologic characteristics, prognosis and gene expression of DTC with anaplastic foci. Materials and Methods: Eighteen patients with DTC with anaplastic foci were enrolled in this study. To compare the clinicopathologic characteristics and prognosis of anaplastic foci subjects with conventional ATC or DTC, we additionally included 12 ATC and 1030 DTC patients who diagnosed during same period. Immunohistochemistry was performed to check the gene expression in anaplastic foci and DTC component. Results: In anaplastic foci group, tumor size was larger (2.5±1.3 vs. 1.2±0.9 cm, p=0.001), distant metastasis was more frequent (11.1 vs. 0%, p=0.000) and 1-year survival rate was low (88.9 vs. 100%, p=0.000) than DTC group. In contrast, compared with ATC group, anaplastic foci group showed younger age at diagnosis (50±16 vs. 63±18 years, p=0.039), smaller tumor size (2.5±1.3 vs. 3.8±1.4 cm, p=0.027), less distant metastasis (11.1 vs. 41.7%, p=0.084) and longer 1-year survival rate (88.9 vs. 25.0%, p=0.001). Expression of p53 protein was observed in 100% of anaplastic foci, ATC and 12.5% of papillary thyroid carcinoma component. Conclusion: DTC with foci of anaplastic transformation has a worse prognosis than DTC, but a better prognosis than ATC. Our results support that DTC with anaplastic foci was intermediate state from DTC to ATC.
Introduction
Anaplastic thyroid carcinoma (ATC) is rare and accounts for only 2% of thyroid cancer. 1) However ATC is the most aggressive form of thyroid cancer, so overall median survival is limited to months. Despite this poor prognosis, some patients with ATC survived relatively longer periods after diagnosis of ATC. In previous studies, long-term survival is possible when patient is younger age and tumor has smaller size, localizes in thyroid parenchyma and can be completely resected by surgery. [2] [3] [4] Currently, it is generally accepted that ATC does not arise de novo but rather transforms or evolves from differentiated thyroid carcinoma (DTC). 5, 6) ATC is commonly related with previous or concurrent thyroid disorders, including DTC. 7, 8) This pathological association of ATC with DTC has led to the emergence of the concept of anaplastic transformation which means an intratumoral evolution or progression from DTC to ATC. 9) According to the Surveillance, Epidemiology and End Results (SEER) Program of National Cancer
Institute, incidence of ATC has decreased by 22% during 1973-2003. 10) In contrast, recent study reported that ATC with coexistent DTC was significantly increased from 1995 to 2010. 11) These results suggested that the incidence of ATC was decreased by early elimination of anaplastic transformation. In addition, the prognosis of DTC including small foci of anaplastic transformation was better than expected than ATC. 11) However, due to scarcity, there are still not many reports of DTC with small foci of ATC.
The aim of the present study is to examine the clinicopathologic characteristics, prognosis and gene expression of DTC with small foci of anaplastic transformation. Diaminobenzidine was used as a chromogen, and the sections were counterstained with Mayer's hematoxylin. As a negative control, non-immune serum was substituted for the primary antibody.
Materials and Methods
Nuclear staining for p53, cyclin D1 was interpreted positive, if more than 50% of cancer cell showed strong nuclear reactivity. Cytoplasmic Bcl-2 and thy- 
Comparison of Cumulative Survival of Anaplastic Foci, DTC and ATC Group
The cumulative survival curves of three patient groups (DTC, anaplastic foci and ATC) are shown in Fig. 1 . Anaplastic foci group survived significantly lon- 
Result of Immunohistochemistry Stating
To compare the gene expression of anaplastic foci and PTC, we performed immunohistochemistry staining both anaplastic foci and PTC components. We also stained ATC for comparison of gene expression. In immunohistochemistry staining, expression of p53 protein was observed in 100% of anaplastic foci, ATC and 12.5% of PTC component. Expression of E-cadherin, thyroglobulin and Bcl-2 was decreased in anaplastic foci and ATC ( Table 2) .
Comparison of Clinicopathologic Characteristics between Survivor and Death in Anaplastic Foci Group
Among 18 anaplastic foci patients, 2 patients were died due to brain metastasis (Table 3 After surgery, 12 patients were received postoperative RT (2 Gy per fraction, once a day; total dose 58-66
Gy) and 4 patients were treated with two or three times radioactive iodine (RAI) therapy (Table 3 ).
Age at diagnosis is younger (47±14 vs. 75±4 years, p=0.013), total tumor size was smaller (2.2±1.2 vs. 4.3±1.1 cm, p=0.052) in survivor group than death group. Other pathological characteristics, such as extrathyroidal invasion, multiplicity and lymph node metastasis were not different between survivor and death group (data not shown).
Discussion
In this study, we examined clinicopathologic characteristics and prognosis of DTC with small (less than 10% of total surface) anaplastic foci group compared with DTC and ATC group. In cumulative survival, anaplastic foci group showed shorter survival rate than DTC group but longer survival rate than ATC group.
In addition, anaplastic foci group was mild and had better prognosis than ATC group, although it was more aggressive and showed poor prognosis than While it is possible that ATC may arise de novo, it has been generally accepted that ATC can develop from pre-existing DTC. 5, 6, 12) Several evidences support the fact that ATC derives from DTC. One is that ATC concurrent with DTC was found about 50%
(23-71%) in several cohort studies about ATC patients. 5, 7, 8, 13) In a study analyzing entire tumor sections, every ATC contained components of papillary or follicular carcinoma or both. 14) Second evidence is that BRAF mutation was found in ATC with PTC component. In pooled data using 29 studies, overall prevalence of BRAF mutation of 44% in PTC and 24%
in ATC and 0% in medullary and follicular thyroid cancer. 15) BRAF was mutated in 78% of ATCs with papillary thyroid cancer background. 16) In addition, BRAF mutations were identified in the papillary component and poorly differentiated or anaplastic carcinoma area arising from PTC at the same time.
17)
However, we could not examine BRAF mutation in anaplastic foci in this study, because the foci of anaplastic tumor were so small, we could not get enough DNA sample from foci of anaplastic tumor.
ATC is nearly always fatal, however sometimes ATC showed long term survival when anaplastic transformation is focal, encapsulated, or tumors can be entirely resected. 2, 18, 19) In this study, most of anaplastic foci group showed long term survival and 66.7% (12/18) patients were younger than 60 years old.
Considering the peak incidence of ATC is six to seventh decade of life, most of our patients were detected very early. Only two patients (No 15, 18, Table 3 ) died due to brain metastasis and they were over 70 years old. Therefore, old age might be considered as a poor prognostic factor and if anaplastic foci were found in elderly, it will be necessary to check whether anaplastic thyroid cancer is metastatic.
Because the strategy to treat DTC with anaplastic foci patients was not established so far, we performed RT for 12 patients and RAI therapy for 4 patients after total thyroidectomy. All four patients in RAI group were survived more than 2 years and still alive until now.
The sodium iodine symporter (NIS) mediated iodine uptake to thyroid allows diagnostic thyroid scintigraphy as well as effective therapeutic application of radioiodine in thyroid cancer. Because the expression of NIS is decreased in ATC, ATC does not accumulate I-131 and therefore is refractory to RAI therapy. 20, 21) However, if the patients had thyroid cancer which contained only small component of intrathyroidal ATC and was completely resected, RAI therapy may be considered for ablation of PTC. 22) In previous study, both RAI and RT were effective for the improvement of survival of DTC with anaplastic foci and showed no significant difference. 23) Therefore, more research is needed to find out which treatment is more appropriate for DTC with anaplastic foci.
In conclusion, DTC with anaplastic foci has a worse prognosis than DTC, but have a better prognosis than ATC. Our results support that DTC with anaplastic foci was intermediate state from DTC to ATC.
